Skip to main content
SpringerLink
Log in
Book cover

New Solutions for the Heart pp 41–55Cite as

Sites of Injury: Myocyte

  • Chapter
  • First Online:

  • 639 Accesses

Abstract

As a surgeon, it is important to understand the pathophysiology of the disease process that causes the requirement for surgery. The predominant pathophysiologies influencing adult patients to require surgery is ischaemic heart disease, and myocardial hypertrophy as a result of valvular problems such as stenosis and regurgitation. Inevitably, there will be a certain degree of overlap in the effect of these pathophysiologies on the heart as a whole, and also on different components of the heart: the myocyte, the endothelium and the conductance system. This chapter will briefly describe effects of the pathology on the myocyte, how these pathologies may be affected by the additional stresses imposed by the surgery and by the cardioprotective methods used during the surgery.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Becker LB (2004). New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 61(3): 461–470.

    Article  PubMed  CAS  Google Scholar 

  • Bers DM (2002). Cardiac excitation-contraction coupling. Nature 415(6868): 198–205.

    Article  PubMed  CAS  Google Scholar 

  • Boengler K, Schulz R, Heusch G (2009). Loss of cardioprotection with ageing. Cardiovasc Res 83(2): 247–261.

    Article  PubMed  CAS  Google Scholar 

  • Bolli R, Marban E (1999). Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 79(2): 609–634.

    PubMed  CAS  Google Scholar 

  • Braunwald E, Bristow MR (2000). Congestive heart failure: fifty years of progress. Circulation 102(20 Suppl 4): IV14–IV23.

    PubMed  CAS  Google Scholar 

  • Burns PG, Krukenkamp IB, Caldarone CA, Gaudette GR, Bukhari EA, Levitsky S (1995). Does cardiopulmonary bypass alone elicit myoprotective preconditioning? Circulation 92(9 Suppl): II447–II451.

    Article  Google Scholar 

  • Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, Holtby HM, Cox PN, Smallhorn JF, Van Arsdell GS, Redington AN (2006). Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 47(11): 2277–2282.

    Article  PubMed  Google Scholar 

  • Di Lisa F, Bernardi P (2006). Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. Cardiovasc Res 70(2): 191–199.

    Article  PubMed  Google Scholar 

  • Doenst T, Bugger H, Schwarzer M, Faerber G, Borger MA, Mohr FW (2008). Three good reasons for heart surgeons to understand cardiac metabolism. Eur J Cardiothorac Surg 33(5): 862–871.

    Article  PubMed  Google Scholar 

  • Downey JM, Cohen MV (2009). Why do we still not have cardioprotective drugs? Circ J 73(7): 1171–1177.

    Article  PubMed  Google Scholar 

  • Downey JM, Davis AM, Cohen MV (2007). Signaling pathways in ischemic preconditioning. Heart Fail Rev 12(3–4): 181–188.

    Article  PubMed  CAS  Google Scholar 

  • Downey JM, Krieg T, Cohen MV (2008). Mapping preconditioning’s signaling pathways: an engineering approach. Ann N Y Acad Sci 1123: 187–196.

    Article  PubMed  CAS  Google Scholar 

  • Ferdinandy P, Schulz R, Baxter GF (2007). Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 59(4): 418–458.

    Article  PubMed  CAS  Google Scholar 

  • Friehs I, del Nido PJ (2003). Increased susceptibility of hypertrophied hearts to ischemic injury. Ann Thorac Surg 75(2): S678–S684.

    Article  PubMed  Google Scholar 

  • Garlick PB, Davies MJ, Hearse DJ, Slater TF (1987). Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res 61(5): 757–760.

    Article  PubMed  CAS  Google Scholar 

  • Garlid KD, Dos Santos P, Xie ZJ, Costa AD, Paucek P (2003). Mitochondrial potassium transport: the role of the mitochondrial ATP-sensitive K(+) channel in cardiac function and cardioprotection. Biochim Biophys Acta 1606(1–3): 1–21.

    PubMed  CAS  Google Scholar 

  • Ghosh S, Galinanes M (2003). Protection of the human heart with ischemic preconditioning during cardiac surgery: role of cardiopulmonary bypass. J Thorac Cardiovasc Surg 126(1): 133–142.

    Article  PubMed  Google Scholar 

  • Granfeldt A, Lefer DJ, Vinten-Johansen J (2009). Protective ischaemia in patients: preconditioning and postconditioning. Cardiovasc Res 83(2): 234–246.

    Article  PubMed  CAS  Google Scholar 

  • Gross GJ, Peart JN (2003). KATP channels and myocardial preconditioning: an update. Am J Physiol Heart Circ Physiol 285(3): H921–H930.

    PubMed  CAS  Google Scholar 

  • Gustafsson AB, Gottlieb RA (2008). Heart mitochondria: gates of life and death. Cardiovasc Res 77(2): 334–343.

    Article  PubMed  CAS  Google Scholar 

  • Halestrap AP (2006). Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans 34(Pt 2): 232–237.

    PubMed  CAS  Google Scholar 

  • Hausenloy DJ, Yellon DM (2007). Preconditioning and postconditioning: united at reperfusion. Pharmacol Ther 116(2): 173–191.

    Article  PubMed  CAS  Google Scholar 

  • Hausenloy DJ, Yellon DM (2008). Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res 79(3): 377–386.

    Article  PubMed  CAS  Google Scholar 

  • Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E, Ashley E, Vichare S, Di Salvo C, Kolvekar S, Hayward M, Keogh B, MacAllister RJ, Yellon DM (2007). Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 370(9587): 575–579.

    Article  PubMed  Google Scholar 

  • Hearse DJ, Bolli R (1992). Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc Res 26(2): 101–108.

    Article  PubMed  CAS  Google Scholar 

  • Heyndrickx GR (2006). Early reperfusion phenomena. Semin Cardiothorac Vasc Anesth 10(3): 236–241.

    Article  PubMed  Google Scholar 

  • Honda HM, Korge P, Weiss JN (2005). Mitochondria and ischemia/reperfusion injury. Ann NY Acad Sci 1047: 248–258.

    Article  PubMed  CAS  Google Scholar 

  • Hool LC (2007). What cardiologists should know about calcium ion channels and their regulation by reactive oxygen species. Heart Lung Circ 16(5): 361–372.

    Article  PubMed  CAS  Google Scholar 

  • Hool LC, Corry B (2007). Redox control of calcium channels: from mechanisms to therapeutic opportunities. Antioxid Redox Signal 9(4): 409–435.

    Article  PubMed  CAS  Google Scholar 

  • Javadov S, Karmazyn M (2007). Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol Biochem 20(1–4): 1–22.

    Article  PubMed  CAS  Google Scholar 

  • Jennings RB, Steenbergen C, Jr., Reimer KA (1995). Myocardial ischemia and reperfusion. Monogr Pathol 37: 47–80.

    PubMed  CAS  Google Scholar 

  • Kempf T, Wollert KC (2004). Nitric oxide and the enigma of cardiac hypertrophy. Bioessays 26(6): 608–615.

    Article  PubMed  CAS  Google Scholar 

  • Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, Hoschtitzky JA, Vogel M, Sorensen K, Redington AN, MacAllister R (2002). Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 106(23): 2881–2883.

    Article  PubMed  CAS  Google Scholar 

  • Kolocassides KG, Galinanes M, Hearse DJ (1994). Ischemic preconditioning, cardioplegia or both? J Mol Cell Cardiol 26(11): 1411–1414.

    Article  PubMed  CAS  Google Scholar 

  • Luo W, Li B, Lin G, Huang R (2007). Postconditioning in cardiac surgery for tetralogy of Fallot. J Thorac Cardiovasc Surg 133(5): 1373–1374.

    Article  PubMed  Google Scholar 

  • Luo W, Li B, Chen R, Huang R, Lin G (2008). Effect of ischemic postconditioning in adult valve replacement. Eur J Cardiothorac Surg 33(2): 203–208.

    Article  PubMed  Google Scholar 

  • Luo W, Li B, Lin G, Chen R, Huang R (2008). Does cardioplegia leave room for postconditioning in paediatric cardiac surgery? Cardiol Young 18(3): 282–287.

    Article  PubMed  Google Scholar 

  • Maruyama Y, Chambers DJ (2008). Does ischemic postconditioning improve myocardial protection after conventional cardioplegia? J Mol Cell Cardiol 44: 761.

    Article  Google Scholar 

  • Mehta RH, Bruckman D, Das S, Tsai T, Russman P, Karavite D, Monaghan H, Sonnad S, Shea MJ, Eagle KA, Deeb GM (2001). Implications of increased left ventricular mass index on in-hospital outcomes in patients undergoing aortic valve surgery. J Thorac Cardiovasc Surg 122(5): 919–928.

    Article  PubMed  CAS  Google Scholar 

  • Menasche P, Kevelaitis E, Mouas C, Grousset C, Piwnica A, Bloch G (1995). Preconditioning with potassium channel openers. A new concept for enhancing cardioplegic protection? J Thorac Cardiovasc Surg 110(6): 1606–1613; discussion 1613–1604.

    Article  PubMed  CAS  Google Scholar 

  • Murphy E, Eisner DA (2009). Regulation of intracellular and mitochondrial sodium in health and disease. Circ Res 104(3): 292–303.

    Article  PubMed  CAS  Google Scholar 

  • Murphy E, Steenbergen C (2008). Ion transport and energetics during cell death and protection. Physiology (Bethesda) 23: 115–123.

    Article  CAS  Google Scholar 

  • Murry CE, Jennings RB, Reimer KA (1986). Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74(5): 1124–1136.

    Article  PubMed  CAS  Google Scholar 

  • O’Rourke B, Cortassa S, Aon MA (2005). Mitochondrial ion channels: gatekeepers of life and death. Physiology (Bethesda) 20: 303–315.

    Article  Google Scholar 

  • Piper HM, Meuter K, Schafer C (2003). Cellular mechanisms of ischemia-reperfusion injury. Ann Thorac Surg 75(2): S644–648.

    Article  PubMed  Google Scholar 

  • Powers SK, Murlasits Z, Wu M, Kavazis AN (2007). Ischemia-reperfusion-induced cardiac injury: a brief review. Med Sci Sports Exerc 39(9): 1529–1536.

    Article  PubMed  Google Scholar 

  • Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P (1993). Regional ischemic ‘preconditioning’ protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87(3): 893–899.

    Article  PubMed  CAS  Google Scholar 

  • Schaper J, Schaper W (1988). Time course of myocardial necrosis. Cardiovasc Drugs Ther 2(1): 17–25.

    Article  PubMed  CAS  Google Scholar 

  • Solaini G, Harris DA (2005). Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochem J 390(Pt 2): 377–394.

    PubMed  CAS  Google Scholar 

  • Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, Rioufol G, Cung TT, Bonnefoy E, Angoulvant D, Aupetit JF, Finet G, Andre-Fouet X, Macia JC, Raczka F, Rossi R, Itti R, Kirkorian G, Derumeaux G, Ovize M (2008). Long-term benefit of postconditioning. Circulation 117(8): 1037–1044.

    Article  PubMed  CAS  Google Scholar 

  • Vaage J, Valen G (2003). Preconditioning and cardiac surgery. Ann Thorac Surg 75(2): S709–714.

    Article  PubMed  Google Scholar 

  • Valen G (2003). The basic biology of apoptosis and its implications for cardiac function and viability. Ann Thorac Surg 75(2): S656–S660.

    Article  PubMed  Google Scholar 

  • Venugopal V, Ludman A, Yellon DM, Hausenloy DJ (2009). ‘Conditioning’ the heart during surgery. Eur J Cardiothorac Surg 35(6): 977–987.

    Article  PubMed  Google Scholar 

  • Vinten-Johansen J (2007). Postconditioning: a mechanical maneuver that triggers biological and molecular cardioprotective responses to reperfusion. Heart Fail Rev 12(3–4): 235–244.

    Article  PubMed  CAS  Google Scholar 

  • Vinten-Johansen J, Zhao ZQ, Jiang R, Zatta AJ, Dobson GP (2007). Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury. J Appl Physiol 103(4): 1441–1448.

    Article  PubMed  Google Scholar 

  • Yellon DM, Downey JM (2003). Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 83(4): 1113–1151.

    PubMed  CAS  Google Scholar 

  • Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J (2003). Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285(2): H579–H588.

    PubMed  CAS  Google Scholar 

  • Zweier JL, Flaherty JT, Weisfeldt ML (1987). Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci USA 84(5): 1404–1407.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiac Surgical Research/Cardiothoracic Surgery, The Rayne Institute (King’s College London), Guy’s & St. Thomas’ NHS Foundation Trust, St. Thomas’ Hospital, London, SE1 7EH, UK

    David J. Chambers

Authors
  1. David J. Chambers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David J. Chambers .

Editor information

Editors and Affiliations

  1. , Department of Cardiac Surgery, Landesklinikum St. Pölten, Propst Führerstraße 4, St. Pölten, 3100, Austria

    Bruno K. Podesser

  2. St Thomas Hospital, Lambeth Palace Road, London SE1 7EH, United Kingdom

    David J. Chambers

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag/Wien

About this chapter

Cite this chapter

Chambers, D.J. (2011). Sites of Injury: Myocyte. In: Podesser, B., Chambers, D. (eds) New Solutions for the Heart. Springer, Vienna. https://doi.org/10.1007/978-3-211-85548-5_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-85548-5_3

  • Published:

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-85547-8

  • Online ISBN: 978-3-211-85548-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation